Thromboembolism in children with sarcoma

Pediatric Blood and Cancer

Volumn 49, Issue 2, 2007, Pages 171-176

  Athale, Uma ^a,b   Cox, Stephanie ^b   Siciliano, Sabrina ^b   Chan, Anthony K C ^a,b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

^c HENDERSON RESEARCH CENTRE   (Canada)

Author keywords

Cancer; Central venous line; Ewing sarcoma family of tumors; Pediatrics; Sarcoma; Thromboembolism

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADOLESCENT; ANTICOAGULANT THERAPY; ARTICLE; CENTRAL VENOUS CATHETER; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EWING SARCOMA; FEMALE; FIBROSARCOMA; HUMAN; MALE; METASTASIS; OSTEOSARCOMA; PREVALENCE; PRIORITY JOURNAL; RHABDOMYOSARCOMA; RISK FACTOR; SARCOMA; SOLID TUMOR; THROMBECTOMY; THROMBOEMBOLISM; TREATMENT OUTCOME;

ADOLESCENT; ANTICOAGULANTS; CATHETERIZATION, CENTRAL VENOUS; CHILD; DEVICE REMOVAL; DISEASE MANAGEMENT; FEMALE; HEMORRHAGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SARCOMA; SARCOMA, EWING'S; SURVIVAL ANALYSIS; THROMBECTOMY; THROMBOEMBOLISM; THROMBOPHILIA; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 34447260534     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21047     Document Type: Article

References (41)

1. Bick RL. Cancer-associated thrombosis. New Engl J Med 2003;349:109-111.
2. Lee AYY, Levine MN. Venous thromboembolism and cancer: Risks and outcome. Circulation 2003;107:I-17-I-21.
3. Horton J. Venous thrombotic events in cancer: The bottom line. Cancer Control 2005;12:31-37.
4. Sutherland DE, Weitz IC, Liebman HA. Thromboembolic complications of cancer: Epidemiology, pathogenesis, diagnosis, and treatment. Am J Hematol 2003;72:43-52.
5. Sallah S, Wan JY, Nguyen NP. Venous thrombosis in patients with solid tumors: Determination of frequency and characteristics. Thromb Haemost 2002;87:575-579.
6. Lee A, Levine M. Treatment of venous thromboembolism in cancer patients. Cancer Control 2005;12:17-21.
7. Sorenson HT, Mellemkjaer L, Olsen JH, et al. Prognosis of cancers associated with venous thromboembolism. N Engl J Med 2000;343:1846-1850.
8. Kakkar AK. Low molecular weight heparin and survival in patients with malignant disease. Cancer Contol 2005;12:22-30.
9. Athale UH, Wiernikowaski J. Thromboembolic complications in children with cancer. Thromb Res 2006;118:137-152.
10. Andrew M, Vegh P, Johnston M, et al. Maturation of the hemostatic system during childhood. Blood 1992;80:1998-2005.
11. Nowak-Gottl U, Kosch A, Schlegel N. Thromboembolism in newborns, infants, and children. Thromb Haemost 2001;86:464-474.
12. Monagle P, Michelson AD, Bovil E, et al. Antithrombotic therapy in children. Chest 2001;119:344-370S.
13. Mitchell LG, Sutor AN, Andrew M. Hemostasis in childhood acute lymphoblastic leukemia: Coagulopathy induced by disease and treatment. Semin Thromb Haemost 1995;21:390-401.
14. Mitchell LG, Andrew M, Hanna K, et al. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase. Results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastc Leukemia Treated with Asparaginase (PARKAA) study. Cancer 2003;97: 508-516.
15. Athale UH, Chan AKC. Thrombosis in children with acute lymphoblastic leukemia Part I: Epidemiology of thrombosis in children with acute lymphoblastic leukemia. Thromb Res 2003; 111:125-131.
16. Wermes C, Prondzinski M vD, Lichtinghagen R, et al. Clinical relevance of genetic risk factors for thrombosis in pediatric oncology patients with central venous catheters. Eur J Pediatr 1999; 158:S143-S146.
17. Sifontes MT, Nuss R, Hunger SP, et al. The factor V Leiden mutation in children with cancer and thrombosis. Br J Haematol 1997;96:484-489.
18. Glacer DW, Medeiros D, Rollins N, et al. Catheter-related thrombosis in children with cancer. J Pediatr 2001;138:255-259.
19. Knoffler R, Siegert E, Lauterbach I, et al. Clinical importance of prothrombotic risk factors in pediatric patients with malignancy: Impact of central venous lines. Eur J Pediatr 1999;185:S147 -S150.
20. Andrew M, David M, Adams M, et al. Venous thromboembolic complications (VTE) in children: First analyses of the Canadian Registry of VTE. Blood 1994;83:1251-1257.
21. Monagle P, Adams M, Mahoney M, et al. Outcome of pediatric-thromboembolic disease: A report from the Canadian Childhood Thrombophilia Registry. Pediatr Res 2000;47:763-766.
22. Massicotte MP, Dix D, Monagle P, et al. Central venous catheter related thrombosis in children: Analysis of the Canadian registry of venous thromboembolic complications. J Pediatr 1998;133:770-776.
23. van Ommen CH, Heijboer H. Baller HR, et al. Venous thromboembolism in childhood: A prospective two-year registry in The Netherlands. J Pediatr 2001;139:676-681.
24. Athale UH, Chan AKC. Thrombosis in children with acute lymphoblastic leukemia Part II: Pathogenesis of tthrombosis in children with acute lymphoblastic leukemia: Effects of the disease and therapy. Thromb Res 2003;111:199-212.
25. Athale UH, Siciliano SA, Crowther M, et al. Thromboembolism (TE) in children with acute lymphoblastic leukemia (ALL) treated on Dana-Farber Cancer Institute (DFCI) protocols: Effect of age and risk stratification of ALL. Br J Haemetol 2005;129:803-810.
26. Olsson E, Svartling N, Asko-Seljavaara S, et al. Activation of coagulation and fibrinolysis during reconstructive microsurgery in patients with cancer. Microsurgery 2001;21:208-213.
27. Benns M, Dalsing M, Sawchuck A, et al. Soft tissue sarcomas may present with deep venous thrombosis. J Vasc Surg 2006;43:788-793.
28. Bona R. Thrombotic complications of central venous catheters in cancer patients. Semin Thromb Haemost 1999;25:147-153.
29. Freytes CO. Thromboembolic complications related to indwelling central venous catheters in children. Curr Opin Oncol 2003;15: 289-292.
30. Molinari AC, Castagnola E, Mazzola C, et al. Thromboembolic complications related to indwelling central venous catheters in children with oncologic/heamatological diseases: A retrospective study of 362 catheters. Support Care Cancer 2001;9:539-544.
31. Rudd E, Holmstrom H, Natvig S, et al. Prevalence of thrombophilia and central venous catheter-associated neck vein thrombosis in 41 children with cancer - A prospective study. Med Pediatr Oncol 2002;38:405-410.
32. Barnes C, Newall F, Monagle P. Thromboembolic complications related to indwelling central venous catheters in children with oncological/hematological diseases: A retrospective study of 362 catheters. Support Care Cancer 2002;10:256-257.
33. McLean TW, Fisher CJ, Snively BM, et al. Central venous lines in children with lesser risk acute lymphoblastic leukemia: Optimal type and timing of placement. J Clin Oncol 2005;23: 3024-3029.
34. Lee AYY, Levine MN, Butler G, et al. Incidence, risk factors and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol 2006;24:1404-1408.
35. Nowak-Gottl U, Munchow N, Klippel U, et al. The course of fibrinolytic proteins in children with malignant bone tumors. Eur J Pediatr 1999; 158:S151-S153.
36. Canadian Cancer Statistics, 2005. www.cancer.ca
37. Cancer incidence and survival among children and adolescents: United States SEER program 1975-1995. National Cancer Institute.
38. Gale AJ, Gordon SG. Update on tumor cell procoagulant factors. Acta Hematol 2001;106:25-32.
39. Bloom JW, Doggen CJM, Osanto S, et al. Malignancies, prothrombotic mutations and the risk of venous thrombosis. JAMA 2005;293:715-722.
40. Male C, Chait P, Ginsberg JS, et al. Comparison of venography and ultrasound for the diagnosis of asymtomatic deep venous thrombosis in the upper body in children. Thromb Haemost 2002;87:593-598.
41. Monagle P, Chan AKC, Albisetti M, et al. Fibrinolytic system in adolescents; response to venous occlusion stress tests. Pediatr Res 2003;53:333-337.